Skip to search formSkip to main contentSkip to account menu

FGN-1

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

sulindac sulfone

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Sulindac Sulfone Is Most Effective in Modulating β‐Catenin‐Mediated Transcription in Cells with Mutant APC
Abstract: Sulindac sulfone (FGN‐1, Aptosyn), a metabolite of the nonsteroidal anti‐inflammatory drug sulindac, lacks… 
2004
2004
A Phase I and Pharmacokinetic Study of Exisulind and Docetaxel in Patients with Advanced Solid Tumors
Purpose: Exisulind (sulindac sulfone, FGN-1, Aptosyn) is a sulindac metabolite that induces apoptosis via inhibition of cyclic… 
Highly Cited
1998
Highly Cited
1998
Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung tumor formation by FGN-1 (sulindac sulfone).
The sulfone derivative of the non-steroidal anti-inflammatory drug (NSAID), sulindac, has been reported to inhibit mammary and… 
1998
1998
Sulindac sulfone (FGN-1) in patients with familial adenomatous polyposis (FAP): Polyp effect and tolerability from an open label extension trial
1995
1995
Determination of FGN-1 (an active metabolite of sulindac) in human plasma, urine, and feces by HPLC.
1995
1995
Sulindac sulfide (SS) and sulfone (FGN-1) both inhibit the growth of colon cancer cell lines by inducing apoptosis
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)